- Home
- NAGE vs TVIV Comparison
NAGE vs TVIV Comparison
Compare NAGE & TVIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.43
Company Overview
Basic Information| Metric | NAGE | TVIV |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 206.5M |
| IPO Year | 2010 | 2025 |
Fundamental Metrics
Financial Performance| Metric | NAGE | TVIV |
|---|---|---|
| Price | $2.43 | $9.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.08 | N/A |
| AVG Volume (30 Days) | ★ 521.4K | 31.9K |
| Earning Date | 11-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.82 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $129,423,000.00 | N/A |
| Revenue This Year | $2.85 | N/A |
| Revenue Next Year | $16.67 | N/A |
| P/E Ratio | $27.83 | ★ N/A |
| Revenue Growth | ★ 29.95 | N/A |
| 52 Week Low | $2.43 | $9.85 |
| 52 Week High | $7.95 | $9.97 |
Technical Indicators
Market Signals| Indicator | NAGE | TVIV |
|---|---|---|
| Relative Strength Index (RSI) | 29.44 | 58.32 |
| Support Level | N/A | $9.85 |
| Resistance Level | $3.61 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 2.99 | 100.00 |
Price Performance
Historical Comparison NAGE
TVIV
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About TVIV Texas Ventures Acquisition IV Corp Class A Ordinary Shares
Texas Ventures Acquisition IV Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.